Marcus R. Pereira, MD, MPH
Appointments
Connect Patient Portal
For existing patients, login to make an appointment, view documentation or contact your care provider.
Credentials & Experience
Board Certifications
- Infectious Disease
- Internal Medicine
Clinical Expertise
- Infectious Disease
- Transplanted Organ and Tissue Infection
- HIV/AIDS
- Transplant Related Infections
Specialties
Education & Training
- University of Florida College of Medicine
- Residency: NewYork-Presbyterian Hospital/Columbia University Medical Center
- Fellowship: NewYork-Presbyterian Hospital/Columbia University Medical Center
Honors & Awards
- Viginia Apgar Academy Educational Scholar Award, 2016
- Ewig Clinical Scholar for Excellence in Medical Education, 2013
- Medical Housestaff Teaching Award for Junior Attending, 2012
- Hospitalist Resident of the Year, 2007
- Alpha Omega Alpha, University of Florida College of Medicine, 2004
About Marcus Pereira
Dr. Marcus Pereira is an Assistant Clinical Professor of Medicine at the Columbia University College of Physicians. As a specialist, Dr. Pereira is focused on infectious complications among patients with solid organ and bone marrow transplant as well as hematological malignancies and provides care in both inpatient and outpatient settings. Establishing and now directing the Transplant Infectious Diseases Program at Columbia, Dr. Pereira oversees the development of infection prophylaxis and treatment protocols for immunocompromised patients.His current areas of interest include multi-drug resistant infections, including bacterial and fungal organisms among renal and liver transplant patients as well as resistant CMV infections.
Academic Titles
- Assistant Professor of Medicine at CUMC
Administrative Positions
- Medical Director, Transplant Infectious Disease Program
Hospital Affiliations
- NewYork-Presbyterian/Columbia
Languages
- Spanish
- Portuguese
Gender
- Male
Insurance Accepted
Aetna
- EPO
- HMO
- Medicare Managed Care
- NY Signature
- NYP Employee Plan
- POS
- PPO
- Signature Administrators
- Student Health
Affinity
- Essential Plan
- Medicaid Managed Care
AgeWell
- Medicare Managed Care
- Special Needs Plan
Amida Care
- Special Needs Plan
Capital District Physician Health Plan
- Capital District Physician Health Plan
Cigna
- EPO
- Great West
- HMO
- POS
- PPO
Elderplan
- Medicare Managed Care
Emblem/GHI
- Medicare Managed Care
- PPO
Emblem/HIP
- ConnectiCare
- EPO
- Essential Plan
- HMO
- Medicaid Managed Care
- Medicare Managed Care
- POS
- PPO
- Select Care (Exchange)
- Vytra
Empire Blue Cross Blue Shield
- EPO
- Medicare Managed Care
- PPO
Empire Blue Cross Blue Shield HealthPlus
- Child/Family Health Plus
- Essential Plan
- Medicaid Managed Care
Fidelis Care
- Child/Family Health Plus
- Medicaid Managed Care
- Medicare Managed Care
Healthfirst
- Child/Family Health Plus
- Leaf (Exchange)
- Medicaid Managed Care
- Medicare Managed Care
Local 1199
- Local 1199
MagnaCare
- MagnaCare
Medicare
- Traditional Medicare (NY)
Multiplan
- Multiplan
MVP Health Care
- Child/Family Health Plus
- Essential Plan
- HMO
- Medicaid Managed Care
Oxford Health Plans
- Freedom
- Liberty
- Medicare Managed Care
UnitedHealthcare
- Columbia University Employee Plan
- Compass (Exchange)
- HMO
- Medicaid (Community Plan)
- Medicare Managed Care
- POS
- PPO
VNSNY CHOICE
- Medicare Managed Care
- SelectHealth
- Special Needs Plan
WellCare
- Medicaid Managed Care
- Medicare Managed Care
*Please contact the provider’s office directly to verify that your particular insurance is accepted.
Contact & Locations
Room 2-242
New York, New York 10032
Research
Research Interests
- Multidrug resistant infections
- CMV and resistant CMV
- HIV and Organ transplantation
- C. Difficile infections
Grants
CLINICAL PERFORMANCE OF THE APTIMA? CMV QUANT ASSAY ON THE PANTHER? SYSTEM (P&S Industry Clinical Trial)
Apr 22 2019 - Apr 22 2024
A PHASE III, RANDOMIZED, DOUBLE-BLIND, COMPARATOR-CONROLLED STUDY TO EVALUATE THE EFFICACY AND SAFETY OF MK-8228 (LETERMOVIR) VERSUS VALGANCICLOVIR FOR THE PREVENTION OF HUMAN CYTOMEGALOVIRUS (CMV) DISEASE IN ADJULT KIDNEY TRANSPLANT RECIPIENTS (P&S Industry Clinical Trial)
Jul 19 2018 - Jul 19 2023
REGULATORY T CELLS TO PROMOTE MIXED CHIMERISM FOR TOLERANCE TO ISLETS ANDKIDNEYS FROM DECEASED AND LIVING DONORS (Federal Gov)
Aug 18 2017 - Jul 31 2022
HUMAN ANTI-VIRAL IMMUNE RESPONSES IN TISSUES AND CIRCULATION (Federal Gov)
Jan 1 2017 - Dec 31 2021
HOPE IN ACTION: A CLINICAL TRIAL OF HIV-TO-HIV LIVER TRANSPLANTATION (Federal Gov)
Jan 1 2019 - Jul 31 2020
HOPE IN ACTION: A CLINICAL TRIAL OF HIV-TO-HIV DECEASES DONOR KIDNEY TRANSPLANTATION (Federal Gov)
Jan 1 2018 - Jul 31 2018
A PHASE 2, RANDOMIZED STUDY TO ASSESS THE SAFETY AND ANTI-CYTOMEGALOVIRUS (CMV) ACTIVITY OF DIFFERENT DOSES OF MARIBAVIR FOR TREATMENT OF CMV INFECTIONS (P&S Industry Clinical Trial)
Jun 4 2013 - Jun 4 2018
ESTABLISHMENT OF DONOR CHIMERISM USING ALLOGENEIC BONE MARROW WITH AMP CELL CO-INFUSION (Federal Gov)
Aug 15 2015 - Aug 14 2017
Selected Publications
Greendyke W, Pereira MR, “Infections complications and vaccinations in the post-transplant population”, Edited by David Sass and Alden Doyle, “Care of the Liver and Kidney Transplant Recipient”, Medical Clinics of North America, 2016 May;100(3): 587-98. Elsevier.
Pereira MR, Uhlemann AC. The evolving threat of carbapenem-resistant infections after liver transplantation: The case of Acinetobacter baumannii. Liver Transpl. 2016 May;22(5):579-81
Benamu E, Pereira MR, Delli Carpini K, Huprikar S, Taimur S, Patel G, Friedman AL, Jenkins SG, Herold BC, Madan RP: Utility of Respiratory Cultures in the Evaluation of deceased Organ Donors. Accepted for ICAAC 2015 in San Diego, CA
Pouch SM, Kubin CJ, Satlin MJ, Tsapepas DS, Lee JR, Dube G, Pereira MR. Epidemiology and outcomes of carbapenem-resistant Klebsiella pneumoniae bacteriuria in kidney transplant recipients. Transpl Infect Dis. 2015 Dec;17(6):800-9. doi: 10.1111/tid.12450. Epub 2015 Nov 5.
DeLuca IJ, Patel VA, Pereira MR, Grossman ME. A new polyomavirus-related dermatosis in a pancreatic transplant patient. JAAD Case Rep. 2015 Nov 24;1(6):S38-40. doi: 10.1016/j.jdcr.2015.09.018. eCollection 2015 Nov.
Pereira MR, Scully BF, Pouch SM, Uhlemann AC, Goudie S, Emond JE, Verna EC. Risk Factors and Outcomes of Carbapenem-Resistant Klebsiella pneumoniae Infections in Liver Transplant Recipients. Liver Transpl. 2015 Jul 1. [Epub ahead of print]
Gray EB, Benedict T, Rivera H, Huprikar S, Zakowski P, Kubak B, Pereira MR, Dhand A, Kransdorf EP, Stenehjem E, Katugaha S, Schmidt M, Stocks L, Delli Carpini K, Fuentes JR, Kiros LS, Montgomery S: Trypanosoma cruzi infections in solid organ transplant recipients, 2014. Accepted for oral presentation at IDWeek 2015 in San Diego, CA
Aaron JG, Pereira MR: Utilization of an Interferon-Gamma Release Assay Increases Compliance for Latent Tuberculosis Screening Among Liver Transplant Candidates: ICAAC 2014 T-1799
Mishra N, Pereira M, Rhodes RH, An P, Pipas JM, Jain K, Kapoor A, Briese T, Faust PL, Lipkin WI. Identification of a Novel Polyomavirus in a Pancreatic Transplant Recipient with Retinal Blindness and Vasculitic Myopathy. J Infect Dis. 2014 Nov 15;210(10)
Shah, S, Tsapepas D, Kubin C, Martin S, Mohan S, Ratner L, Pereira M. Kapur S, Dadhania D, Walker-McDermott J. Risk factors associated with Clostridium difficile infection after kidney and pancreas transplantation. Transplant Inf Dis 2013 Oct;15(5):502-9
Wright K, Young P, Brickman C, Sam T, Badjatia N, Pereira M, Connolly ES, Yin MT. Rates and determinants of ventriculostomy-related infections during a hospital transition to use of antibiotic-coated external ventricular drains. Neurosurg Focus. 2013 May;34(5):E12.
Brown RS Jr, Verna EC, Pereira M, Tilson HH, Aguilar C, Leu CS, Buti M, Fagan EA. Hepatitis B virus and human immunodeficiency virus drugs in pregnancy: findings from the Antiretroviral Pregnancy Registry. J Hepatol. 2012 Nov;57(5):953-9.